← Eichor
Study identifier: NCT07512505 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Remote Vital Sign Monitoring in Palliative Care Patients Using a Wearable ECG Monitor

Condition: Cancer · Malignancies Multiple · Terminal Care  ·  Sponsor: Our Lady's Hospice and Care Services

PhaseN/A
Planned participants120
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this study is the assess the use of remote monitoring of vital signs using commercially available medical devices in patients with advanced cancer admitted to a hospice inpatient unit for end-of-life care. The objectives of the study are: 1. could remote monitoring of vital signs improve patient care through the earlier identification of infections and other (potentially reversible) problems; 2. could remote monitoring of vital signs improve the accuracy of our estimates about how long a person has to live; and c) determine the relationship between complaints of pain / other symptoms and vital signs.

This description comes directly from the study's public registry record.

Talk to the study team

Hailey Goffinet, MSN  ·  +353 014982537  ·  hgoffinet@olh.ie

Professor Andrew Davies  ·  +353 014986235  ·  andavies@tcd.ie

Always discuss trial participation with your own doctor first.

Locations (1)

Our Lady's Hospice and Care ServicesDublin, IrelandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07512505